Excluded participant
obstipation, gastrointestinal symptoms, gastroenteritis, stomachache
ADVERSE EVENTS, OBSTIPATION, GASTROENTERITIS
One individual, a male, who received double dose AB001 during phase one, was excluded due to adverse events. He reported on day 159 that he had severe stomachache, obstipation, and concurrent vomiting. There was no gastroenteritis observed among friends and family. The study team instructed him to stop taking probiotics and thereby discontinue the study participation. He did not require any medical assistance. Four to five days after stop taking probiotics, he reported that he had a normal gastrointestinal function again. As a safety precaution he was taken back for a check-up. Approximately 1 month after not taking the probiotic compound he had no gastrointestinal symptoms. From baseline, the individual had lost 2.3 kg in weight, corresponding to a decrease in BMI of 0.69 kg/m